Evidence map›Paper›PMID 25797621›Full record

ArticleBiochemical and biophysical research communications2015

The Tomato yellow leaf curl virus (TYLCV) V2 protein inhibits enzymatic activity of the host papain-like cysteine protease CYP1.

Amalia Bar-Ziv, Yael Levy, Vitaly Citovsky, Yedidya Gafni

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Plants (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Amalia Bar-ZivInstitute of Plant Sciences, A.R.O., The Volcani Center, P.O. Box 6, Bet Dagan 50250, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.
Yael LevyInstitute of Plant Sciences, A.R.O., The Volcani Center, P.O. Box 6, Bet Dagan 50250, Israel.
Vitaly CitovskyDepartment of Biochemistry and Cell Biology, State University of New York, Stony Brook, New York, USA.
Yedidya GafniInstitute of Plant Sciences, A.R.O., The Volcani Center, P.O. Box 6, Bet Dagan 50250, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel. Electronic address: ygafni@volcani.agri.gov.il.
Bar-Ilan University · ILAgricultural Research Organization · ILState University of New York · US

Funding

TRANSPORT THROUGH PLASMODESMATAR01GM050224 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI CITOVSKY, VITALY H · 1994 to 2020
$5.7M
NIGMS NIH HHS R01 GM050224NIGMS NIH HHS R01 GM50224
6 · The paper itself

Abstract

The viral V2 protein is one of the key factors that Tomato yellow leaf curl geminivirus (TYLCV), a major tomato pathogen worldwide, utilizes to combat the host defense. Besides suppressing the plant RNA silencing defense by targeting the host SGS3 component of the silencing machinery, V2 also interacts with the host CYP1 protein, a papain-like cysteine protease likely involved in hypersensitive response reactions. The biological effects of the V2-CYP1 interaction, however, remain unknown. We addressed this question by demonstrating that V2 inhibits the enzymatic activity of CYP1, but does not interfere with post-translational maturation of this protein.

Indexed as

BegomovirusBlotting, WesternCysteine ProteasesProtein Processing, Post-TranslationalProteolysisViral ProteinsCysteine ProteasesViral ProteinsCYP1Papain-like cysteine proteaseProgrammed cell deathTYLCVV2 protein

Identifiers

PMID25797621
PMCPMC4439401
OpenAlexW2017513134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.